Literature DB >> 3485459

T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia.

N Berliner, A D Duby, D C Linch, C Murre, T Quertermous, L J Knott, T Azin, A C Newland, D L Lewis, M C Galvin.   

Abstract

We have used probes from the T cell receptor beta and gamma chain loci to investigate the clonality of T lymphocytes in eight patients with T cell lymphocytosis and cytopenia (TCLC). This syndrome, which is strongly associated with rheumatoid arthritis, is characterized by peripheral blood and bone marrow lymphocytosis and neutropenia, red cell aplasia, or both. By means of T cell monoclonal antibodies and flow cytometry, T lymphocytes from patients with this syndrome have been shown to have characteristic immunologic features. Investigators have disagreed as to whether the syndrome represents a T cell malignancy or a more benign immunologic disorder. DNA from five of five patients with symptomatic "classic" T cell lymphocytosis with cytopenia demonstrated unique rearrangements of the T cell receptor beta chain locus, whereas neither of two patients with atypical features showed rearrangement. In addition, we found evidence for gamma chain rearrangement in those DNAs with clonal beta chain rearrangement. We thus postulate that the classic form of this syndrome is associated with a monoclonal proliferation of T cells. Its potential relationship to T cell chronic lymphocytic leukemia is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485459

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis.

Authors:  Andrew E Schade; Jennifer J Powers; Marcin W Wlodarski; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

2.  T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells.

Authors:  J R Bender; R Pardi; E Engleman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia.

Authors:  Vivek Subbiah; Aaron D Viny; Steven Rosenblatt; Brad Pohlman; Alan Lichtin; Jaroslaw P Maciejewski
Journal:  Exp Hematol       Date:  2008-06-11       Impact factor: 3.084

4.  Lymphocytosis of large granular lymphocytes associated with anemia and neutropenia: proof of monoclonality of the LGL-population, but benign clinical course.

Authors:  S Serke; A Neubauer; D Huhn
Journal:  Klin Wochenschr       Date:  1989-06-01

5.  Large granular lymphocytosis associated with rheumatoid arthritis.

Authors:  A Samanta; I Grant; F E Nichol; J H Pringle; J K Wood; A C Campbell
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

6.  Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome.

Authors:  M J Ahern; P J Roberts-Thomson; J Bradley; C Story; P Seshadri
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

7.  CD3+ CD8+ T cell lymphocytosis masking B cell leukaemia.

Authors:  J L Smith; D G Oscier; D G Haegert; D B Jones; M Howell; E Hodges; F K Stevenson; T J Hamblin
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

8.  Lymphocytosis: is it leukaemia and when to treat.

Authors:  E A Macintyre; D C Linch
Journal:  Postgrad Med J       Date:  1988-01       Impact factor: 2.401

9.  Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease).

Authors:  L M Weiss; G S Wood; L W Ellisen; T C Reynolds; J Sklar
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

Review 10.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.